INIFY LABORATORIES AB (F:WY60) — Market Cap & Net Worth
Market Cap & Net Worth: INIFY LABORATORIES AB (WY60)
INIFY LABORATORIES AB (F:WY60) has a market capitalization of $30.74 Million (€26.29 Million) as of August 1, 2026. Listed on the F stock exchange, this Germany-based company holds position #23624 globally and #2064 in its home market, demonstrating a 6.86% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying INIFY LABORATORIES AB's stock price €0.55 by its total outstanding shares 107474845 (107.47 Million). Review INIFY LABORATORIES AB balance sheet liabilities to assess the company's total debt and financial obligations.
INIFY LABORATORIES AB Market Cap History: 2022 to 2026
INIFY LABORATORIES AB's market capitalization history from 2022 to 2026. Data shows change from $96.25 Million to $68.48 Million (-5.07% CAGR).
INIFY LABORATORIES AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how INIFY LABORATORIES AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.29x
INIFY LABORATORIES AB's market cap is 1.29 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $122.38 Million | $1.19 Million | -$53.33 Million | 102.58x | N/A |
| 2024 | $43.22 Million | $13.13 Million | -$51.64 Million | 3.29x | N/A |
| 2025 | $28.40 Million | $22.01 Million | -$67.89 Million | 1.29x | N/A |
Competitor Companies of WY60 by Market Capitalization
Companies near INIFY LABORATORIES AB in the global market cap rankings as of August 1, 2026.
Key companies related to INIFY LABORATORIES AB by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $215.77 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #169 globally with a market cap of $137.72 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #577 globally with a market cap of $46.48 Billion USD ( CN¥317.64 Billion CNY).
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #616 globally with a market cap of $43.83 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $215.77 Billion | $574.30 |
| #169 | Danaher Corporation | NYSE:DHR | $137.72 Billion | $194.98 |
| #577 | WuXi AppTec Co Ltd | SHG:603259 | $46.48 Billion | CN¥128.43 |
| #616 | IDEXX Laboratories Inc | NASDAQ:IDXX | $43.83 Billion | $559.07 |
INIFY LABORATORIES AB Historical Marketcap From 2022 to 2026
Between 2022 and today, INIFY LABORATORIES AB's market cap moved from $96.25 Million to $ 68.48 Million, with a yearly change of -5.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €68.48 Million | +141.15% |
| 2025 | €28.40 Million | -34.30% |
| 2024 | €43.22 Million | -64.68% |
| 2023 | €122.38 Million | +27.15% |
| 2022 | €96.25 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of INIFY LABORATORIES AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $30.74 Million USD |
| MoneyControl | $30.74 Million USD |
| MarketWatch | $30.74 Million USD |
| marketcap.company | $30.74 Million USD |
| Reuters | $30.74 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About INIFY LABORATORIES AB
INIFY Laboratories AB provides cancer diagnostics services in Sweden. It offers prostate cancer diagnostics services. The company was incorporated in 2021 and is based in Stockholm, Sweden.